Why promoter design is no longer just an expression checkbox, it’s the key to therapeutic endurance:
Advanced therapies Why promoter design is no longer just an expression checkbox, it’s the key…
Presented by
Dr. Joris van Arensbergen
Founder & CEO, Annogen
Combined with Twist Bioscience’s oligo synthesis platform, SuRE™ unlocks the ability to screen rationally designed libraries at unprecedented scale and sensitivity, with applications across biopharma, medicine, and agriculture.
View the Twist webinar →
Learn more about SuRE™ Technology →
We use cookies to personalize content, provide social media features, and analyze our traffic. We also share information about your use of our site with our analytics partners. You can change your preferences at any time. For more information, please see our Privacy Policy and Cookie Policy.